FOXO3 and colorectal carcinoma: The results indicated FOXO3 was significantly enriched on the promoters of CTNNB1 and p27 after the treatment of PS341 in HCC and CRC cells mainly resulting from the elevated expression of FOXO3 (Fig. 6d).